Abstract:The emergence of the aggregation-induced emission (AIE) concept significantly changes the cognition of the scientific community toward classic photophysical phenomena. More importantly, the AIE phenomenon has brought huge opportunities for the analysis of bioactive species, the monitoring of complicated biological processes, and the elucidation of key physiological and pathological behaviors. As a class of promising luminescent materials, AIE luminogens (AIEgens) are weakly or non-emissive in the form of isolated molecular species but emit particularly strong fluorescence in the aggregated and solid states. Motivated by the prominent advantages such as high brightness, large Stokes shift, excellent photostability, and good biocompatibility, AIEgen-based bioprobes have been widely explored in the field of biomedicine. This review aims to provide a systematic summary of the developmental history and an in-depth perspective of the current landscape of AIE in the biomedical field, with an emphasis on the discussions of major working principles. The milestones of the historical development of AIE in the biomedical field are first reviewed. A total of four major research directions are then extracted, including biomacromolecule sensing (at the molecular level), in vitro cell imaging (at the cellular level), in vivo imaging (at the animal level), and cancer theranostics (at the cellular and animal levels), together with clear-cut tables showing comprehensive cases for further study. Lastly, this review is concluded by the discussions of several perspectives on future directions. It is believed that AIEgen-based bioprobes will play vital roles in the exploration of mysterious life processes by integration with various cutting-edge modalities and techniques with an ultimate goal of addressing more healthcare issues.

Comprehensive Review of Protein Imaging with AIEgens Conjugated Probes: from Concentration to Conformation

Imaging: Conjugated Polymer Amplified Far‐Red/Near‐Infrared Fluorescence from Nanoparticles with Aggregation‐Induced Emission Characteristics for Targeted in Vivo Imaging (adv. Healthcare Mater. 3/2013)

Bioimaging: Biocompatible Nanoparticles with Aggregation‐Induced Emission Characteristics as Far‐Red/Near‐Infrared Fluorescent Bioprobes for in Vitro and In Vivo Imaging Applications (Adv. Funct. Mater. 4/2012)

Application of AIE-active Molecules in Biosensing

Reaction‐based AIE‐active Fluorescent Probes for Selective Detection and Imaging

Application of novel AIE materials in fluorescence probes

The Bioimaging Story of AIEgens

Visualizing intracellular dynamics with AIE probes

Aggregation‐induced Emission Luminogens for in Vivo Molecular Imaging and Theranostics in Cancer

Intracellularly Manipulable Aggregation of the Aggregation-Induced Emission Luminogens

Long-Term Fluorescent Cellular Tracing By The Aggregates Of Aie Bioconjugates

Aggregation-Induced Emission: A Trailblazing Journey to the Field of Biomedicine

AIE Luminogens for Bioimaging and Theranostics: from Organelles to Animals

Fabrication of hybridized nanoparticles with aggregation-induced emission characteristics and application for cell imaging

Aggregation Induced Emission Based Luminogenic (AIEgenic) Probes for the Biomarker Detection

Optical Molecular Imaging and Theranostics in Neurological Diseases Based on Aggregation-Induced Emission Luminogens

Aggregation‐induced Emission Based Fluorogens for Mitochondria‐targeted Tumor Imaging and Theranostics

Rational Design of Crystallization-Induced-Emission Probes To Detect Amorphous Protein Aggregation in Live Cells

Fundamentals and exploration of aggregation-induced emission molecules for amyloid protein aggregation

Recent Advances and Perspectives of Aggregation-Induced Emission As an Emerging Platform for Detection and Bioimaging

Biocompatible organic dots with aggregation-induced emission for in vitro and in vivo fluorescence imaging